Yahoo
NasdaqCM - Delayed Quote USD

BioNexus Gene Lab Corp. (BGLC)

0.9175 -0.0625 (-6.38%)
At close: October 30 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Su-Leng Tan
CEO, President, Secretary & Director 446.02k -- 1983
Ms. Set Fui Chong
Chief Financial Officer 42.27k -- 1963
Mr. Kwan Wah Chan
Marketing Manager -- -- --
Mr. Too Kam Tham
Managing Director -- -- --

BioNexus Gene Lab Corp.

Menara UOA Bangsar
Unit A-28-7, Level 28, Tower A No.5 Jln Bangsar Utama 1
Kuala Lumpur, 59000
Malaysia
60 1 307 241 6898 https://www.bionexusgenelab.com
Sector: 
Basic Materials
Industry: 
Specialty Chemicals
Full Time Employees: 
19

Description

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Corporate Governance

BioNexus Gene Lab Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

October 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 28, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 14, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

March 31, 2026 at 12:00 AM UTC

NT 10-K: Periodic Financial Reports

March 17, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 23, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 3, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: